Quantrx Biomedical Corporation operates in the Surgical and medical instruments sector. QuantRx Biomedical Corporation (QuantRx) is a diagnostics company focused on the development and commercialization of point-of-care (POC) diagnostic products based on its technology platforms for the worldwide healthcare industry. The Company's platforms include RapidSense POC testing products based on QuantRx core intellectual property related to lateral flow methods, devices, and processes for the consumer and healthcare professional markets; PAD products based on QuantRx technology for aiding the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, and other medical needs, including diagnostic sampling products, which enable self collection and worldwide transport; Single Nucleotide Polymorphism (SNP) chips; genome-based diagnostic chips for the laboratory and healthcare professional markets, and molecular imaging agents for Positron Emission Tomography (PET), with initial application in cardiovascular disease. In our complete report available for purchase the company is compared to: Nephros, Inc., Nanosphere, Inc. and Ceragenix Pharmaceuticals, Inc..